参考文献

[1] 丛文铭,吴孟超.肝癌分子病理诊断新思路与临床治疗新策略.中华医学杂志,2014,94(20):1521-1523.

[2] 丛文铭,吴孟超.我国肝脏外科病理学研究回顾与展望.中华肝脏病杂志,2013,21(2):90-92.

[3] Edmondson HA.Tumors of the liver and intrahepatic bile ducts.Atlas of tumors pathology.Washington DC:Armed Forces Institinte of Pathology,1958.

[4] 丛文铭,吴孟超,陈汉,等.肝脏局灶性结节性增生二例.临床肝胆病杂志,1991,7(2):112.

[5] 丛文铭,吴孟超.局灶性肝脂肪变四例报告.第二军医大学学报,1992,13(1):93-94.

[6] 丛文铭,吴孟超,陈汉.肝脏血管平滑肌脂肪瘤一例.中华外科杂志,1992,30(10):618.

[7] 丛文铭,吴孟超,陈汉.肝细胞腺瘤样增生3 例.中华医学杂志,1993,73(4):212.

[8] Zhu Z,Guo J,Dong H.Primary chondrosarcoma of the liver:a case report and review of the literature.J Med Coll PLA,2011,26(3):128-133.

[9] Zhao Q,Su CQ,Dong H,et al.Hepatocellular carcinoma and hepatic adenocarcinosarcoma in a patient with hepatitis B virus-related cirrhosis.Semin Liver Dis,2010,30(1):107-112.

[10] Cong WM,Wu MC,Wang Y,et al.Primary liver tumors in China:A clinicopathological study of 3,160 cases.Oncol Rep,1997,4(3):649-652.

[11] 丛文铭.肝胆肿瘤病理学彩色图谱.上海:上海科技文献出版社,1998.

[12] 丛文铭,朱世能.肝胆肿瘤诊断外科病理学.上海:上海科技教育出版社,2002.

[13] Cong WM,Dong H,Tan L,et al.Surgicopathological classification of hepatic space-occupying lesions:a single-center experience with literature review.World J Gastroenterol,2011,19(17):2372-2378.

[14] 丛文铭,吴孟超.肝脏及肝内胆管系统肿瘤的外科病理学特点.中华肝胆外科杂志,2008,14(5):358-360.

[15] Anthony PP,Vogel CL,Barker LF.Liver cell dysplasia:a premalignant condition.J Clin Pathol,1973,26(3):217-223.

[16] Cong WM,Wu MC.Significance of clinicopathology in quantitative measurement of DNA content in hepatocellular carcinoma.J Med Coll PLA,1988,3(2):153-156.

[17] Cong WM,Wu MC,Zhang XZ.Quantitative studies on the DNA content and morphological features of liver cell dysplasia.Chin J Cancer Res,1989,3(1):21-23.

[18] Dong H,Cong WM,Xian ZH,et al.Using loss of heterozygosity of microsatellites to distinguish high-grade dysplastic nodule from early minute hepatocellular carcinoma.Exp Mol Pathol,2011,91(2):578-583.

[19] Jin GZ,Li Y,Cong WM,et al.iTRAQ-2DLC-ESI-MS/MS based identification of a new set of immunohistochemical biomarkers for classification of dysplastic nodules and small hepatocellular carcinoma.J Proteome Res,2011,10(8):3418-3428.

[20] Jin GZ,Yu WL,Dong H,et al.SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma.J Hepatol,2013,59(3):510-517.

[21] 刘海平,丛文铭.肝细胞腺瘤:分子病理学新认识与临床诊治新模式.临床肝胆病杂志,2013,29(11):801-804.

[22] Demetris A,Adams D,Bellamy C,et al.Update of the International Banff Schema for Liver Allograft Rejection:working recommendations for the histopathologic staging and reporting of chronic rejection.An International Panel.Hepatology,2000,31(3):792-799.

[23] Cong WM,Bakker A,Swalsky PA,et al.Multiple genetic alterations involved in the tumorigenesis of human cholangiocarcinoma:a molecular genetic and clinicopathological study.J Cancer Res Clin Oncol,2001,127(3):187-192.

[24] 丛文铭,张淑英,王政禄,等.肝移植665 例穿刺活检病理诊断总结.中华病理学杂志,2005,34(11):716-719.

[25] 全国肝胆肿瘤及移植病理协作组.肝移植术后常见病变的病理诊断与分级指南(Ⅰ).中华器官移植杂志,2008,29(1):49-51.

[26] 全国肝胆肿瘤及移植病理协作组.肝移植术后常见病变的病理诊断与分级指南(Ⅱ).中华器官移植杂志,2009,10:626-628.

[27] 丛文铭,陆新元,董辉,等.肝移植术后急性排异的病理类型与转归:附1120 例次肝穿刺分析.临床与实验病理学杂志,2011,27(2):117-120.

[28] 丛文铭,董辉.肝移植术后小肝综合征的组织学观察一例.中华器官移植杂志,2010,31(10):635-636.

[29] 丛文铭,王政禄.我国肝脏移植病理学的发展回顾与思考.器官移植,2011,2(3):121-124.

[30] 丛文铭.肝脏移植临床病理学.北京:军事医学科学出版社,2011.

[31] Zhu ZZ,Cong WM,Liu SF,et al.A p53 polymorphism modifies the risk of hepatocellular carcinoma among noncarriers but not carriers of chronic hepatitis B virus infection.Cancer Lett,2005,229(1):77-83.

[32] 潘晶,丛文铭.肝细胞腺瘤肿瘤抑制基因杂合性缺失分析.临床与实验病理学杂志,2003,19(5):481-483.

[33] Wang B,Xia CY,Lau WY,et al.Determination of clonal origin of recurrent hepatocellular carcinoma for personalized therapy and outcomes evaluation:a new strategy for hepatic surgery.J Am Coll Surg,2013,217(6):1054-1062.

[34] Ishak KG,Goodman ZD,Stocker JT.Tumors of the liver and intrahepatic bile ducts.Atlas of Tumor Pathology.Washington DC:Armed Forces Institinte of Pathology,2001.

[35] 汤钊猷.从生物学角度看肝癌治疗趋势.中华肝胆外科杂志,2009,6:401-402.

[36] 吴孟超.原发性肝癌的诊断及治疗进展.中国医学科学院学报,2008,30(4):363-365.

[37] 丛文铭,吴孟超.重视对肝脏肿瘤病理生物学特性的研究.中华外科杂志,2010,48(15):1121-1124.

[38] 丛文铭.关于建立肝胆系统肿瘤病理生物学诊断模式的思考.临床与实验病理学杂志,2013,29(1):3-5.

[39] Cong WM,Wu MC.The biopathologic characteristics of DNA content of hepatocellular carcinomas.Cancer,1990,66(3):498-501.

[40] Cong WM,Wu MC,Zhang XZ.Characteristic changes of DNA stemlines during hepatocarcinogenesis in rats.Chin Med J(Engl),1992,105(7):535-538.

[41] 丛文铭,吴孟超,陈汉.小肝细胞癌的临床病理特点(附93 例分析).中华肿瘤杂志,1993,15(5):372-374.

[42] 丛文铭,吴孟超.小肝癌临床病理学研究回顾与展望.中华肝胆外科杂志,2011,17(5):353-356.

[43] Cong WM,Wu MC.Small hepatocellular carcinoma-current and future approaches.Hepatol Int,2013,7(3):805-812.

[44] Lu XY,Xi T,Lau WY,et al.Pathobiological features of small hepatocellular carcinoma:correlation between tumor size and biological behavior.J Cancer Res Clin Oncol,2011,137(4):567-575.

[45] 丛文铭,董辉,冼志红.肝脏和肝内胆管系统肿瘤.见:吴秉铨,刘彦仿.免疫组织化学病理诊断.北京:北京科学技术出版社,2013.

[46] Lu XY,Xi T,Lau WY,et al.Hepatocellular carcinoma expressing cholangiocyte phenotype is a novel subtype with highly aggressive behavior.Ann Surg Oncol,2011,18(8):2210-2217.

[47] 丛文铭,赵新.乳腺癌术后13 年肝脏和结肠转移1 例.中国实用外科杂志,1999,19(6):335-335.

[48] 丛文铭,吴孟超,陈汉.肝癌切除后八年腹膜复发一例.上海医学,1993,16(2):119.

[49] Cong WM,Wu MC,Chen H,et al.Studies on the clinical significance of the clonal origins of recurrent hepatocellular carcinoma.Chin Med Sci J,1992,7(2):101-104.

[50] 朱玉瑶,顾怡瑾,陆新元,等.二例术后远期复发性肝细胞癌的克隆特点分析.中华肿瘤杂志,2014,36(6):450-452.

[51] 中国抗癌协会肝癌专业委员会,中国抗癌协会临床肿瘤学协作专业委员会,中华医学会肝病学会肝癌学组.原发性肝癌规范化病理诊断方案专家共识.中华医学杂志,2011,91(12):802-804.

[52] 国际肝胆胰学会中国分会,中华医学会外科学分会肝脏外科学组.胆管癌诊断与治疗—外科专家共识.中国实用外科杂志,2014,34(1):1-5.